<DOC>
	<DOCNO>NCT01745718</DOCNO>
	<brief_summary>The investigator evaluate accuracy perform cytological imprint target biopsy diagnose prostate cancer . It useful know whether biopsy cancer , order know stop sampling continue . The strategy use type cancer , e.g lung , breast etc</brief_summary>
	<brief_title>Clinical Study Evaluating Targeted Biopsies Cytological Imprints Prostate Cancer</brief_title>
	<detailed_description>Background : When substitute random biopsy procedure target biopsy , outmost importance know immediately biopsy positive . A recent study demonstrate high sensitivity specificity imprint cytology random biopsy . Aim : The correlation cytological imprint histology target prostate biopsy Material &amp; Method : All patient study already participate ongoing randomize biopsy study ( NCT01455792 ) comparing : 1 . Preoperative MRI target biopsy + random biopsy . 2 . Random biopsy ( gold standard ) . Only patient positive MRI include collateral study . The cytological imprint ( negative/positive ) target biopsy compare histology ( negative/positive ) Gleason score .</detailed_description>
	<mesh_term>Prostatic Neoplasms</mesh_term>
	<criteria>Prostate specific antigene ( PSA ) 420ng/ml , and/or abnormal digital rectal examination No previous prostate biopsy Positive MRI Signed letter inform concent Contraindications MRI Previous prostate biopsy</criteria>
	<gender>Male</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2015</verification_date>
	<keyword>prostate cancer</keyword>
	<keyword>target biopsy</keyword>
	<keyword>cytological imprint</keyword>
	<keyword>histology</keyword>
</DOC>